| 영문 | soft palate | 한글 | 물렁입천장, 연구개 |
|---|---|---|---|
| 설명 | 입속의 천장을 구성하며 동시에 콧구멍의 바닥을 이루는 구조물을 입천장이라 한다. 입천장은 크게 2가지로 나뉘어져 앞쪽의 뼈로 이루어진 부분을 단단입천장(hard palate)라 하고, 뒷부분의 근육성 주름을 물렁입천장(soft palate)라 한다. 주된 구조물은 건막과 근육 그리고 림프 조직이며 한가운데에는 목젖(uvula)이라고 하는 돌기가 존재한다. 목젖의 옆으로는 두개의 주름 즉 입천장혀활(palatoglossal arch)과 입천장인두궁(palatopharyngeal arch)이 존재하며 이 두 주름사이에 입천장편도(palatine tonsil)가 있다. 연구개의 기능은 음식을 삼킬 때 그 뒷끝이 인두의 뒷벽에 닿음으로써 음식물이 코로 역류하지 못하게 한다. |
||
| ABCDES | abnormal alignment, bones-periarticular osteoporosis, cartilage-joint space loss, deformities, margi... |
|---|---|
| BLT | bleeding time; blood-clot lysis time; blood test |
| CLT | Certified Laboratory Technician; chronic lymphocytic thyroiditis; Clinical Laboratory Technician; cl... |
| CPF | clot-promoting factor; complication probability factor; contraction peak force; current patient file... |
| CR | calculation rate; calculus removed; calorie-restricted; cardiac rehabilitation; cardiac resuscitatio... |
| ECLT | Euglobulin Clot Lysis time |
|---|---|
| ASPS | Alveolar soft part sarcoma |
| NSS | Neurological soft signs |
| PSE | Pale, soft, exudative |
| STS | Soft Tissue Sarcomas |
| agonal clot | Intravascular thrombosis ascribed to the process of dying. (05 Mar 2000) |
|---|---|
| antemortem clot | A blood clot, found at autopsy, formed in any of the heart cavities or the great vessels before death. (05 Mar 2000) |
| blood clot | <haematology> The conversion of blood from a liquid form to solid through the process of coagulation. A thrombus is a clot which forms inside of a blood vessel. If that clot moves inside the vessel it is referred to as an embolus (embolism). The presence of atherosclerotic plaque lining blood vessel walls is a significant stimulus for clot formation. (27 Sep 1997) |
| passive clot | A clot formed in an aneurysmal sac consequent to the cessation or slowing of circulation through the aneurysm. (05 Mar 2000) |
| medication, clot-dissolving | Drugs used to dissolve blood clots. Agents such as plasminogen-activator (t-pa) and streptokinase that are effective in dissolving clots and re-opening arteries. Used, for example, in the treatment of heart attacks. Clot-dissolvers are also called thrombolytic agents. (12 Dec 1998) |
| chicken fat clot | Clot formed in vitro or postmortem from leukocytes and plasma of sedimented blood. (05 Mar 2000) |
| clot | 1. To coagulate, said especially of blood. 2. A soft, nonrigid, insoluble mass formed when a liquid (e.g., blood or lymph) gels. Origin: O.E. Klott, lump (05 Mar 2000) |
| clot-dissolving medications | Agents such as plasminogen-activator (t-PA) and streptokinase that are effective in dissolving clots and re-opening arteries. Used, for example, in the treatment of heart attacks. Also called thrombolytic agents. (12 Dec 1998) |
| clot retraction | Retraction of a clot resulting from contraction of platelet pseudopods attached to fibrin strands that is dependent on the contractile protein thrombosthenin. Used as a measure of platelet function. (12 Dec 1998) |
| clot retraction time | The time required for a blood clot to separate from the tube wall and express serum, usually completed in 18 to 24 hours, but retarded or absent in persons with thrombocytopenic purpura. (05 Mar 2000) |
| mucin clot test | A test that reflects the polymerization of synovial fluid hyaluronate; a few drops of synovial fluid added to acetic acid form a clot; poor clot formation occurs in a variety of inflammatory conditions including septic arthritis, gouty arthritis, and rheumatoid arthritis. Synonym: Ropes test. (05 Mar 2000) |
| postmortem clot | A clot formed in the heart or great vessels after death. (05 Mar 2000) |
| currant jelly clot | A jelly-like mass of red blood cells and fibrin formed by the in vitro or postmortem clotting of whole or sedimented blood. (05 Mar 2000) |
| Schede's clot | Filling of the defect in bone, after removal of a sequestrum or scraping away carious material, by allowing the cavity to fill with blood which may become organised (Schede's clot). (05 Mar 2000) |
| euglobulin clot lysis time | A measure of the ability of plasminogen activators and plasmin to lyse a clot; normally, clot lysis is determined by the balance of factors which activate fibrinolysis (plasminogen activators and plasmin) and those which inhibit lysis; in certain conditions (e.g., carcinoma or hepatic insufficiency) activating factors predominate and can be measured by noting the time it takes the euglobulin fraction of plasma (excluding inhibitors of fibrinolysis) to clot. (05 Mar 2000) |
제품명 |
판매사 |
보험코드 | 성분/함량 | 구분/보험급여 |
|---|
제품명 |
판매사 |
보험코드 | 성분/함량 | 구분/보험급여 |
|---|